Showing 1 - 10 of 157
Background:Background: In 2005, the French Government implemented a new way of financing high-cost drugs for hospitals in order to promote innovation. Such drugs are gathered on a positive list, established by the Ministry of Health, with a reimbursement price cap. Hospitals still negotiate with...
Persistent link: https://www.econbiz.de/10011005079
Background: The debate on US healthcare reform has largely focused on the introduction of a public health plan option. While supporters stress various beneficial effects that would arise from increased competition in the health insurance market, opponents often contend that a public plan would...
Persistent link: https://www.econbiz.de/10008620558
Persistent link: https://www.econbiz.de/10008677587
Background: A common way of describing UK National Institute for Health and Clinical Excellence (NICE) decisions is to distinguish between cases where NICE recommended use of a healthcare technology by all relevant patients ('yes'); those where it did not recommend use ('no'); and those where...
Persistent link: https://www.econbiz.de/10008677588
Persistent link: https://www.econbiz.de/10008690228
Persistent link: https://www.econbiz.de/10008725816
This paper investigates the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. The effect of the vintage of prescription drugs (and other variables) on the life expectancy and age-adjusted mortality rates of residents of Germany is examined, using...
Persistent link: https://www.econbiz.de/10009493381
Health systems are placing more and more emphasis on the design and delivery of services that are focused on the patient, and there is a growing interest in patient involvement in health policy research and health technology assessment (HTA). Furthermore, there is a growing research interest in...
Persistent link: https://www.econbiz.de/10010614433
The National Institute for Health and Clinical Excellence (NICE) is the arms-length National Health Service (NHS) agency that provides recommendations to the NHS in England and Wales on clinical practice and technologies that should or should not be used in the NHS. NICE aims to ensure that both...
Persistent link: https://www.econbiz.de/10010614438
Background:Background: Studies have determined the societal impact of methicillin-resistant Staphylococcus aureus (MRSA) by modelling its impact on labour supply and productivity. In addition, most of the studies on the topic conclude that the problem of resistance should be counteracted on the...
Persistent link: https://www.econbiz.de/10010552622